Exploring the formation of Alzheimer's disease senile plaques in Silico

Journal of Theoretical Biology

Volumn 216, Issue 3, 2002, Pages 301-326

  Edelstein Keshet, Leah ^a   Spiros, Athan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

DISEASE;

ALZHEIMER DISEASE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; DISEASE MODEL; GLIA CELL; HUMAN; INFLAMMATION; MEDICAL ASSESSMENT; MEDICAL INFORMATICS; NERVE CELL NECROSIS; PATHOGENESIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENILE PLAQUE; STRESS;

EID: 0036389411     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2002.2540     Document Type: Article

References (89)

1. AKIYAMA, H., et al. (The Neuroinflammation working group) (1999). Inflammation and Alzheimer's disease. Neurobiol. Aging. 21, 383-421.
2. ARD, M. D., COLE, G. M., WEI, J., MEHRLE, A. P. & FRATKIN, J. D. (1996). Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43, 190-202.
3. BENES, F. M., REIFEL, J. L., MAJOCHA, R. E. & MAROTTA, C. A. (1989). Evidence for a diffusional model of Alzheimer's amyloid A4 beta amyloid deposition during neurotic plaque formation. Neuroscience 33, 483-488.
4. BENJAMIN, D., WORMSLEY, S. & DOWER, S. K. (1990). Heterogeneity in interleukin (IL)-1 receptors expressed on human B cell lines. Differences in the molecular properties of IL-1 alpha and IL-1 beta binding sites. J. Biol. Chem. 265, 9943-9951.
5. BENVENISTE, E. N., TANG, L. P. & LAW, R. M. (1995). Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int. J. Dev. Neurosci. 13, 341-349.
6. BOCCI, V. (1998) Central nervous system toxicity of interferons and other cytokines, J Biol. Regul. Homeost. Agents 2, 107-118.
7. BRUGG, B., DUBREIUL, Y. L., HUBER, G., WOLLMAN, E. E., DELHAYE-BOUCHAUD, N. & MARIANI, J. (1995). Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain, Proc. Natl Acad. Sci. U.S.A. 92, 3032-3035.
8. BUSH, A. I., PETTINGELL, W. H., MULTHAUP, G., PARADIS, M. D., VONSATTEL, J.-P, GUSELLA, J. F., BEYREUTHER, K., MASTERS, C. L. & TANZI, R. E. (1994). Rapid induction of Alzheimer A-beta amyloid formation by zinc. Science 265, 1464-1467.
9. BUXBAUM, J. D., OISHI, M., CHEN, H. I., PINKAS-KRAMARSKI, R., JAFFE, E. A., GANDY, S. E. & GREENGARD P. (1992). Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer's beta A4 amyloid protein precursor. Proc. Natl Acad. Sci. U.S.A. 89, 10075-10078.
10. CAI, X.-D., GOLDE, T. E. & YOUNKIN, S. G. (1993). Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science (Washington, DC). 259, 514-516.
11. CARLSON, N. G., WIEGGEL, W. A., CHEN, J., BACCHI, A., ROGERS, S. W. & GAHRING, L.C. (1999). Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways, J. Immunol. 163, 3963-3968.
12. CHAO, C. C., HU, S., EHRLICH, L. & PETERSON, P. K. (1995). Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9, 355-365.
13. CHENG, B., CHRISTAKOS, S. & MATTSON, M. P. (1994). Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
14. CHRISTIE, R. H., BACSKAI, B. J., ZIPFEL, W. R., WILLIAMS, R. M., KAJDASZ, S. T., WEBB, W. W. & HYMAN, B. T. (2001). Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. J. Neurosci. 21, 858-864.
15. CLARKE, G., COLLINS, R. A., LEAVITT, B. R., ANDREWS, D. F., HAYDEN, M. R., LUMSDEN, C. J. & MCINNES, R. R. (2000). A one-hit model of cell death in inherited neuronal degenerations. Nature 406, 195-199.
16. CLARKE, G., LUMSDEN, C. J. & MCINNES, R. R. (2001). Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. Hum. Mol. Genet. 10, 1-7.
17. COME, J. H., FRASER, P. E. & LANSBURY JR., P. T. (1993). A kinetic model for amyloid formation in the prion Diseases: Importance of seeding, PNAS 90, 5959-5963.
18. CRUZ, L., URBANC, B., BULDYREV, S. V., CHRISTIE, R., GMEZ-ISLA, T., HAVLIN, S., MCNAMARA, M., STANLEY, H. E. & HYMAN, B. T. (1997). Aggregation and disaggregation of senile plaques in Alzheimer disease. Proc. Natl Acad. Sci. U.S.A. 94, 7612-7616.
19. DAVIS, J. B., MCMURRAY, H. F. & SCHUBERT, D. (1992). The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 189, 1096-1100.
20. DING, A. H., SANCHEZ, E., SRIMAL, S. & NATHAN, C. F. (1989). Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J. Biol. Chem. 264, 3924-3929.
21. DONNELLY, R. J., FREIDHOFF, A. J., BEER, B., BLUME, A. J. & VITEK, M. P. (1990) Interleukin-1 stimulates the beta-amyloid precursor protein promoter. Cell Mol. Neurobiol. 10, 485-495.
22. DRIPPS, D. J., BRANDHUBER, B. J., THOMPSON, R. C. & EISENBERG, S. P. (1991). Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 266, 10331-10336.
23. EDDERSHAW, P. J., BERESFORD, A. P. & BAYLISS, M. K. (2000). ADME/PK as part of a rational approach to drug discovery. Drug Discovery Today 5, 409-414.
24. EDELSTEIN-KESHET, L. (1998). Mathematical Models in Biology. New York, McGraw Hill.
25. EKINCI, F. J., LINSLEY, M.-D. & SHEA, T. B. (2000). Beta-Amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. Mol. Brain Res. 76, 389-395.
26. EL KHOURY, J., HICKMAN, S. E., THOMAS, C. A., CAO, L., SILVERSTEIN, S. C. & LOIKE, J. D. (1996). Scavenger receptor-mediated adhesion of microglia to beta-Amyloid fibrils. Nature 382, 716-719.
27. ENDY, D., YOU, L., YIN, J. & MOLINEUX, I. J. (2000). Computation, prediction, and experimental tests of fitness for bacteriophage T7 mutants with permuted genomes. Proc. Natl Acad. Sci. U.S.A. 97, 5375-5380.
28. FASSBENDER, K., SIMMONS, M., BERGMANN, C., STROICK, M., LUTJOHANN, D., KELLER, P., RUNZ, H., KUHL.S., BERTSCH, T., VON BERGMANN, K., HENNERICI, M., BEYREUTHER, K. & HARTMANN, T. (2001). Simvastatin strongly reduces levels of Alzheimer's disease Beta-amyloid peptides A beta-42 and A beta-40 in vitro and in vivo. PNAS, online edition.
29. FIALA, M., ZHANG, L., GAN, X., SHERRY, B., TAUB, D., GRAVES, M. C., HAMA, S., WAY, D., WEINAND, M., WITTE, M., LORTON, D., KUO, Y. M. & ROHER, A. E. (1998). Amyloid-beta induces chemokine secretion and monocyte migration across human blood-brain barrier model. Mol. Med. 4, 480-489.
30. FINK, C. C., SLEPCHENKO, B., MORARU, I. I., WATRAS, J., SCHAFF, J. & LOEW, L. M. (2000). An image-based model of calcium waves in differentiated neuroblastoma cells. Biophys. J. 79, 163-183.
31. FORLONI, G., DEMICHELLI, F., GIORGI, S., BENDOTTI, C. & ANGRETTI, N. (1992). Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain. Res. 16, 128-134.
32. GELBARD, H. A., DZENKO, K. A., DILORETO, D., DEL CERRO, C., DEL CERRO, M. & EPSTEIN, L.G. (1993). Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15, 417-422.
33. GIULIAN, D., LI, J., LEARA, B. & KEENEN, C. (1994). Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture, Neurochem. Int. 25, 227-233.
34. GODARD, A., HEYMANN, D., RAHER, S., ANEGON, I., PEYRAT, M. A., LE, MAUFF, B., MOURAY, E., GREGOIRE, M., VIRDEE, K., SOULILLOU, J. P., MOREAU, J. F. & JACQUES, Y. (1992). High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J. Biol. Chem. 267, 3214-3222.
35. GOODHILL, G. J. (1997). Diffusion in axon guidance. Eur. J. Neurosc. 9, 1414-1421.
36. GRAY, C. P. & KECK, W. (1999). Bacterial targets and antibiotics: genome-based drug discovery. Cell. Mol. Life Sci. 56, 779-787.
37. Griffin, W. S. T., Sheng, J. G. & Mrak, R. E. (1996). Inflammatory pathways, In: Molecular Mechanisms of Dementia: (Wasco, W., Tanzi, R. E. eds). Totowa, NJ: Humana Press.
38. GRIFFIN, W. S. T., SHENG, J. G., ROYSTON, M. C., GENTLEMAN, S. M., MCKENZIE, J. E., GRAHAM, D. I., ROBERTS, G. W. & MRAK, R. E. (1998). Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8, 65-72.
39. HAMMACHER, A., SIMPSON, R. J. & NICE, E. C. (1996). The interleukin-6 (IL-6) partial antagonist (Q159E,T162P) IL-6 interacts with the IL-6 receptor and gp130 but fails to induce a stable hexameric receptor complex. J. Biol. Chem. 271, 5464-5473.
40. HARDT, S. L. (1981). The diffusion transit times: a simple derivation. Bull. Math. Biol. 43, 89-99.
41. HORUK, R., HUANG, J. J., COVINGTON, M. & NEWTON, R. C. (1987). A biochemical and kinetic analysis of the interleukin-1 receptor. Evidence for differences in molecular properties of IL-1 receptors. J. Biol. Chem. 262, 16275-16278.
42. HU, J. & VAN ELDIK, L. J. (1999). Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation. Brain Res. 842, 46-54.
43. HUANG, X., ATWOOD, C. S., HARTSHORN, M. A., MULTHAUP, G., GOLDSTEIN, L. E., SCARPA, R. C., CUAJUNGCO, M. P., GRAY, D. N., LIM, J., MOIR, R. D., TANZI, R. E. & BUSH, A. I. (1999a). The A peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38, 7609-7616.
44. HUANG, X., CUAJUNGCO, M. P., ATWOOD, C. S., HARTSHORN, M. A., TYNDALL, J. D. A., HANSON, G. R., STOKES, K. C., LEOPOLD, M., MULTHAUP, G., GOLD-STEIN, L. E., SCARPA, R. C., SAUNDERS, A. J., LIM, J., MOIR, R. D., GLABE, C., BOWDEN, E. F., MASTERS, C. L., FAIRLIE, D. P., TANZI, R. E. & BUSH, A. I. (1999b). Cu(II) potentiation of Alzheimer a neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274, 37 111-37 116.
45. HYMAN, B. T., WEST, H. L., REBECK, G. W., BULDYREV, S. V., MANTEGNA, R. N., UKLEJA, M., HAVLIN S. & STANLEY, H. E. (1995). Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular Epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). PNAS 92, 3586-3590.
46. ITAGAKI, S., MCGEER, P. L., AKIYAMA, H., ZHU, S. & SELKOE, D. (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182.
47. JEOHN, G. H., KONG, L. Y., WILSON, B., HUDSON, P. & HONG, J. S. (1998). Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol. 85, 1-10.
48. KIM, W. G., MOHNEY, R. P., WILSON, B., JEOHN, G. H., LIU, B. & HONG, J. S. (2000). Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316.
49. KLEGERIS, A., WALKER, D. G. & MCGEER, P. L. (1999). Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by nonsteroidal anti-inflammatory drugs (NSAIDS). Neuropharmacology 38, 1017-1025.
50. KORNYEI, Z., CZIROK, A., VICSEK, T. & MADARASZ, E. (2000). Proliferative and migratory responses of astrocytes to in vitro injury. J. Neurosci. Res. 61, 421-429.
51. LEE, S. C., LIU, W., DICKSON, D. W., BROSNAN, C. F. & BERMAN, J. W. (1993). Cytokine production by human fetal microglia and astrocytes, differential induction by lipopolysaccharide and IL-1-beta. J. Immunol. 150, 2659-2667.
52. MA, T. C. & ZHU, X. (2000). Neurotoxic effects of interleukin-6 and sodium nitroprusside on cultured rat hippocampal neurons. Arzneimittelforschung 50, 512-514.
53. MAZEL, T., SIMONOVA, Z. & SYKOVA, E. (1998). Diffusion heterogeneity and anisotropy in rat hippocampus. Neuroreport. 9, 1299-1304.
54. MICHISHITA, M., YOSHIDA, Y., UCHINO, H. & NAGATA, K. (1990). Induction of tumor necrosis factor-alpha and its receptors during differentiation in myeloid leukemic cells along the monocytic pathway. A possible regulatory mechanism for TNF-alpha production. J. Biol. Chem. 265, 8751-8759.
55. MCGEER, E. G. & MCGEER, P. L. (1999). Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharmaceut. Des. 5, 821-836.
56. MCGEER, P. L. & MCGEER, E. G. (1998a). Mechanisms of cell death in Alzheimer disease - immunopathology. J. Neural Transmission. (Suppl.) 54, 159-166.
57. MCGEER, E. G. & MCGEER, P. L. (1998b). The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33, 371-378.
58. MCGEER, P. L. & MCGEER, E. G. (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain. Res. Brain. Res. Rev. 21, 195-218.
59. MCLEAN, C. A., CHERNY, R. A., FRASER, F. W., FULLER, S. J., SMITH, M. J., BEYREUTHER, K., BUSH, A. I. & MASTERS, C. L. (1999). Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860-866.
60. MICHAELIS, M. L., RANCIAT, N., CHEN, Y., BECHTEL, M., RAGAN, R., HEPPERLE, M., LIU, Y. & GEORG, G. (1998). Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol). J. Neurochem. 70, 1623-1627.
61. MOGHE, P. V., NELSON, R. D. & TRANQUILLO, R. T. (1995). Cytokine-stimulated chemotaxis of human neutrophils in a 3-D conjoined fibrin gel assay. J. Immunol. Methods 180, 193-211.
62. MOIR, R. D., ATWOOD, C. S., ROMANO, D. M., LAURANS, M. H., HUANG, X., BUSH, A. I., SMITH, J. D. & TANZI, R. E. (1999). Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A using physiological concentrations. Biochemistry 38, 4595-4603.
63. MRAK, R. E., SHENG, J. G. & GRIFFIN, W. S. T. (1995). Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26, 816-823.
64. MRAK, R. E., SHENG, J. G. & GRIFFIN, W. S. T. (2000). Glial cytokines in neurodegenerative conditions. In: Neuro-lmmune Interactions in Neurologic and Psychiatric Disorders (Patterson, P. H., Kordon, C., Christen, Y. eds). Berlin Heidelberg: Springer-Verlag.
65. Nicholson, C. & Sykova, E. (1998). Extracellular space structure revealed by diffusion analysis. Trends in Neurosciences 21, 207-215.
66. NOLTE, C., MOELLER, T., WALTER, T. & KETTENMANN, H. (1996). Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience 73, 1091-1107.
67. NOLTE, C., KIRCHHOFF, F. & KETTENMANN, H. (1997). Epidermal growth factor is a motility factor for microglial cells in vitro: evidence for EGF receptor expression. Eur. J. Neurosc. 9, 1690-1698.
68. NORRIS, D. A., LEESMAN, G. D., SINKO, P. J. & GRASS, G. M. (2000). Development of predictive pharmacokinetic simulation models for drug discovery. J. Control. Release 65, 55-62.
69. PALSSON, B. (2000). The challenges of in silico biology. Nat. Biotechnol. 18, 1147-1150.
70. PENNICA, D., LAM, V. T., MIZE, N. K., WEBER, R. F., LEWIS, M., FENDLY, B. M., LIPARI, M. T. & GOEDDEL, D. V. (1992). Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation. J. Biol. Chem. 267, 21 172-21 178.
71. PRESS, W. H., FLANNERY, B. P., TEUKOLSKY, S. A. & VETTERLING, W. T. (1988). Numerical Recipes in C: the Art of Scientific Computing. Cambridge: Cambridge Press.
72. RIVERO, M. A., TRANQUILLO, R. T., BUETTNER, H. M. & LAUFFENBURGER, D. A. (1989). Transport models for chemotactic cell populations based on individual cell behaviour. Chem. Eng. Sci. 44, 2881-2897.
73. SCHAFF, J., FINK, C., SLEPCHENKO, B., CARSON, J. & LOEW, L. (1997). A general computational framework for modeling cellular structure and function. Biophys. J. 73, 1135-1146.
74. SELKOE, D. J. (1991). Amyloid protein and Alzheimer's disease. Sci. Am. 265, 68-78.
75. SHAFFER, L. M., DORITY, M. D., GUPTA-BANSAL, R., FREDERICKSON, R. C., YOUNKIN, S. G., BRUNDEN, K. R. (1995). Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
76. SHENG, J. G., ITO, K., SKINNER, R. D., MRAK, R. E., ROVNAGHI, C. R., VAN ELDIK, L. J., GRIFFIN, W. S. T. (1996). In vivo and In vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17, 761-766.
77. SHENG, J. G., MRAK, R. E. & GRIFFIN, W. S. T. (1997). Enlarged and phagocytic, but not primed, inter-leukin-1alpha immunoreactive microglia increase with age in normal human brain. Acta Neuropathol 95, 229-234.
78. STOLL, G., JANDER, S. & SCHROETER, M. (2000). Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J. Neural. Transm. (Suppl) 59, 81-89.
79. STRIKWERDA, J. C. (1989). Finite Dierence Schemes and Partial Dierential Equations. Pacific Grove, CA: Wadsworth and Brooks/Cole Advanced Books and Software.
80. SYKOVA, E. (1997). The extracellular space in the CNS: its regulation, volume, and geometry in normal and pathological neuronal function. Neuroscientist 3, 28-41.
81. SYKOVA, E., MAZEL, T. & SIMONOVA, Z. (1998). Diffusion constraints and neuron-glia interaction during aging. Exp. Gerontol. 33, 837-851.
82. STREIT, W. J. & KINCAID-COLTON, C. A. (1995). The Brain's immune system, Sci. Am. 273, 54-61.
83. TARKOWSKI, E., BLENNOW, K., WALLIN, A., TARKOWSKI, A. (1999). Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin. Immunol. 19, 223-230.
84. TOMITA, M., HASHIMOTO, K., TAKAHASHI, K., SHIMIZU, T. S., MATSUZAKI, Y., MIYOSHI, F., SAITO, K., TANIDA, S., YUGI, K., VENTER, J. C. & HUTCHISON III, C. A. (1999). E-CELL: software environment for whole-cell simulation. Bioinformatics 15, 72-84.
85. URBANC, B., BULDYREV, S. V., CHRISTIE, R., GOMEZ-ISLA, T., HAVLIN, S., MCNAMARA, M., STANLEY, H. E. & HYMAN, B. T. (1997). Aggregation and disaggregation of senile plaques in Alzheimer disease. Proc. Natl Acad. Sci. U.S.A. 94, 7612-7616.
86. URBANC, B., CRUZ, L., BULDYREV, S. V., HAVLIN, S., IRIZARRY, M. C., STANLEY, H. E. & HYMAN, B. T. (1999). Dynamics of plaque formation in Alzheimer's disease. Biophys. J. 76, 1330-1334.
87. VAN WAGONER, N. J., OH, J. W., REPOVIC, P. & BENVENISTE, E. N. (1999). Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J. Neurosci 19, 5236-5244.
88. VON ZAHN, J., MOELLER, T., KETTENMANN, H. & NOLTE, C. (1997). Microglial phagocytosis is modulated by pro-and anti-inflammatory cytokines. Neuroreport 8, 3851-3856.
89. YAMAGUCHI, M., MICHISHITA, M., HIRAYOSHI, K., YASUKAWA, K., OKUMA, M. & NAGATA, K. (1992) Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor. J. Biol. Chem. 267, 22 035-22 042.